© 2025 stocktirumala.com/ | About | Authors | Disclaimer | Privacy

By Raan (Harvard alumni 2025) & Roan (IIT Madras) | Not financial advice

© 2025 stocktirumala.com/ | About | Authors | Disclaimer | Privacy

By Raan (Harvard Alumni 2025) & Roan (IIT Madras) | Not financial advice

biopharmaceutical company

Ramaswamy Vivek Sells $67.9 Million in Shares of Roivant Sciences: What It Means for Investors

Ramaswamy Vivek Sells $67.9 Million in Shares of Roivant Sciences: What It Means for Investors

RAAN December 16, 2025

Introduction to Roivant Sciences and Recent Developments Roivant Sciences is a biopharmaceutical company that...

Ramaswamy Sells $13 Million in Shares of Roivant Sciences (ROIV): Analyzing the Implications

Ramaswamy Sells $13 Million in Shares of Roivant Sciences (ROIV): Analyzing the Implications

RAAN June 23, 2025

Overview of Roivant Sciences (ROIV) Roivant Sciences, a prominent biopharmaceutical company founded in 2014...

© 2025 stocktirumala.com/ | About | Authors | Disclaimer | Privacy

By Raan (Harvard Alumni 2025) & Roan (IIT Madras) | Not financial advice